智通财经APP讯,东方生物(688298.SH)发布公告,公司子公司上海万子健生物科技有限公司及Healgen Scientific LLC(简称“美国衡健”)等多款产品于近期在中国、澳大利亚及新加坡取得医疗器械产品注册证。
上述取证产品丰富了公司流式荧光技术平台的产品种类,呼吸道三联检产品扩大了可销售国际市场,有利于相关产品国内外市场的整体拓展。
智通财经APP讯,东方生物(688298.SH)发布公告,公司子公司上海万子健生物科技有限公司及Healgen Scientific LLC(简称“美国衡健”)等多款产品于近期在中国、澳大利亚及新加坡取得医疗器械产品注册证。
上述取证产品丰富了公司流式荧光技术平台的产品种类,呼吸道三联检产品扩大了可销售国际市场,有利于相关产品国内外市场的整体拓展。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.